PFS
GENE

Prospera Financial Services’s Genetic Technologies Ltd. GENE Stock Holding History

Prospera Financial Services’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 2708
2022
Q1 		$1K Buy
+100
New +$972 ﹤0.01% 2702

Other funds holding GENE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Prospera Financial Services's GENE Position: Q2 2022 in Review

Prospera Financial Services sold out of Genetic Technologies Ltd. (GENE) in Q2 2022, closing a stake of 100 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in GENE in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 12 funds tracked by Wall St. Rank hold GENE as of Q2 2022.

  • Prospera Financial Services reported no remaining Genetic Technologies Ltd. position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 100 Genetic Technologies Ltd. shares in Q2 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in Genetic Technologies Ltd. in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Genetic Technologies Ltd. position peaked at $1K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.